<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://saudenews.org/noticia/fda-amplia-tivicay-tivicay-pd-para-hiv-1-em-recem-nascidos-a-termo-com-peso-mini</loc>
    <news:news>
      <news:publication>
        <news:name>Saúde News</news:name>
        <news:language>pt</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T09:12:43.207Z</news:publication_date>
      <news:title>FDA amplia Tivicay/Tivicay PD para HIV-1 em recém-nascidos a termo com peso mínimo de 2 kg e menos de 4 semanas</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://saudenews.org/noticia/fda-aprova-daraxonrasib-para-adultos-previamente-tratados-ou-inelegiveis-para-te</loc>
    <news:news>
      <news:publication>
        <news:name>Saúde News</news:name>
        <news:language>pt</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T09:07:10.845Z</news:publication_date>
      <news:title>FDA aprova daraxonrasib para adultos previamente tratados ou inelegíveis para terapia multiagente</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://saudenews.org/noticia/imaavy-e-aprovado-no-brasil-para-anemia-hemolitica-autoimune-quente</loc>
    <news:news>
      <news:publication>
        <news:name>Saúde News</news:name>
        <news:language>pt</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T11:34:59.829Z</news:publication_date>
      <news:title>Imaavy é aprovado no Brasil para anemia hemolítica autoimune quente</news:title>
    </news:news>
  </url>
</urlset>